MESA LABS DECLARES QUARTERLY DIVIDEND

Rhea-AI Summary

Mesa Laboratories (NASDAQ:MLAB) has announced a quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record as of August 29, 2025.

Mesa Labs is a global leader specializing in life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Their products and services help ensure product integrity, enhance patient and worker safety, and improve quality of life worldwide.

Positive

• Regular quarterly dividend maintained at $0.16 per share
• Demonstrates commitment to returning value to shareholders
• Company maintains strong market position in life science tools and quality control solutions

Negative

• Dividend amount remains unchanged, showing no growth
• Operating in highly regulated industries with significant compliance requirements

LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.

About Mesa Laboratories, Inc.

Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Forward Looking Statements

This press release may contain information that constitutes forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our historical experience and present expectations or projections.  Forward-looking statements include statements relating to revenues and growth, operating results, profit margin pressure, industry conditions, economic conditions, demand, competition, the effects of additional actions taken to become more efficient or lower costs, risks related to the integration of acquired businesses, changes in legal and regulatory matters, the ability to generate additional cash flow, and any events or developments that we expect or anticipate will occur in the future. Generally, the words “expect,” “anticipate,” “seek,” “intend,” “plan,” “believe,” “could,” “estimate,” “may,” “target,” “project,” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These statements are based upon current information and expectations. Actual results may differ materially from those estimated or anticipated as a result of these risks and unknowns or other risks and uncertainties. For additional information concerning these and other risks and uncertainties that could affect these statements, and our business, see our Annual Report on Form 10-K for the year ended March 31, 2025, as well as other risks and uncertainties detailed from time to time in our reports on Forms 10-Q and 8-K subsequently filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof, to provide any updates, or to reflect the occurrence of future events.

CONTACT: Gary Owens; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000

For more information about the Company, please visit its website at www.mesalabs.com

FAQ

When will Mesa Labs (MLAB) pay its next dividend?

Mesa Labs will pay its quarterly dividend of $0.16 per share on September 15, 2025 to shareholders of record as of August 29, 2025.

What is Mesa Labs' (MLAB) current dividend yield?

Based on the quarterly dividend of $0.16 per share, Mesa Labs pays $0.64 in annual dividends per share. The dividend yield would depend on the current stock price.

What industries does Mesa Laboratories (MLAB) serve?

Mesa Laboratories serves the pharmaceutical, healthcare, and medical device industries, providing life science tools and critical quality control solutions for regulated applications.

Who is eligible for Mesa Labs' Q3 2025 dividend?

Shareholders who own Mesa Labs stock at the close of business on August 29, 2025 (the record date) will be eligible for the dividend payment.